期刊: PHARMACEUTICAL MEDICINE, 2021; 35 (2)
Background Apixaban (ELIQUIS(R)) is a direct oral anticoagulant authorised for multiple indications in the European Economic Area (EEA). Additional ri......
期刊: PHARMACEUTICAL MEDICINE, 2021; 35 (2)
Background Apixaban (ELIQUIS(R)) is a direct oral anticoagulant authorised for multiple indications in the European Economic Area (EEA). Additional ri......